HIV Citation List: June 22 - July 5, 2012

PubMed citations

1. Effects of Sequence Changes in the HIV-1 gp41 Fusion Peptide on CCR5 Inhibitor Resistance. Anastassopoulou, C.G., T.J. Ketas, R.W. Sanders, P. Johan Klasse, and J.P. Moore, Virology, 2012. 428(2): p. 86-97; PMID[22520838].

[PubMed]. HIV_0622-070512.

2. In Vitro anti-HIV-1 Activity in Cervicovaginal Secretions from Pregnant and Nonpregnant Women. Anderson, B.L., M. Ghosh, C. Raker, J. Fahey, Y. Song, D.J. Rouse, C.R. Wira, and S. Cu-Uvin, American Journal of Obstetrics and Gynecology, 2012. 207(1): p. 65 e1-65 e10; PMID[22727351].

[PubMed]. HIV_0622-070512.

3. HIV-1 Gag-virus-like Particles Inhibit HIV-1 Replication in Dendritic Cells and T Cells through IFN-alpha-dependent Upregulation of APOBEC3G and 3F. Chang, M.O., T. Suzuki, N. Yamamoto, M. Watanabe, and H. Takaku, Journal of Innate Immunity, 2012. [Epub ahead of Print]; PMID[22739040].

[PubMed]. HIV_0622-070512.

4. A Peptide Nucleic Acid-aminosugar Conjugate Targeting Transactivation Response Element of HIV-1 RNA Genome Shows a High Bioavailability in Human Cells and Strongly Inhibits Tat-mediated Transactivation of HIV-1 Transcription. Das, I., J. Desire, D. Manvar, I. Baussanne, V.N. Pandey, and J.L. Decout, Journal of Medicinal Chemistry, 2012. [Epub ahead of Print]; PMID[22698070].

[PubMed]. HIV_0622-070512.

5. Residue-ligand Interaction Energy (ReLIE) on a Receptor-Dependent 3D-QSAR Analysis of S- and NH-DABOS as Non-nucleoside Reverse Transcriptase Inhibitors. de Brito, M.A., C.R. Rodrigues, J.J. Cirino, J.Q. Araujo, T. Honorio, L.M. Cabral, R.B. de Alencastro, H.C. Castro, and M.G. Albuquerque, Molecules, 2012. 17(7): p. 7666-7694; PMID[22732882].

[PubMed]. HIV_0622-070512.

6. A Conformationally Frozen Peptoid Boosts CXCR4 Affinity and anti-HIV Activity. Demmer, O., A.O. Frank, F. Hagn, M. Schottelius, L. Marinelli, S. Cosconati, R. Brack-Werner, S. Kremb, H.J. Wester, and H. Kessler, Angewandte Chemie International Edition English, 2012. [Epub ahead of Print]; PMID[22760863].

[PubMed]. HIV_0622-070512.

7. Enhanced anti-HIV Efficacy of Indinavir after Inclusion in CD4 Targeted Lipid Nanoparticles. Endsley, A.N. and R.J. Ho, Journal of Acquired Immune Deficiency Syndrome, 2012. [Epub ahead of Print]; PMID[22743598].

[PubMed]. HIV_0622-070512.

8. Combinations of Griffithsin with Other Carbohydrate-binding Agents Demonstrate Superior Activity against HIV Type 1, HIV Type 2, and Selected Carbohydrate-binding Agent-resistant HIV Type 1 Strains. Ferir, G., D. Huskens, K.E. Palmer, D.M. Boudreaux, M.D. Swanson, D.M. Markovitz, J. Balzarini, and D. Schols, AIDS Research and Human Retroviruses, 2012. [Epub ahead of Print]; PMID[22607556].

[PubMed]. HIV_0622-070512.

9. Chiral Resolution, Absolute Configuration Assignment and Biological Activity of Racemic Diarylpyrimidine CH(OH)-DAPY as Potent Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors. Gu, S.X., Z.M. Li, X.D. Ma, S.Q. Yang, Q.Q. He, F.E. Chen, E. De Clercq, J. Balzarini, and C. Pannecouque, European Journal of Medicinal Chemistry, 2012. 53C: p. 229-234; PMID[22575532].

[PubMed]. HIV_0622-070512.

10. Identification of Old Drugs as Potential Inhibitors of HIV-1 Integrase - Human LEDGF/p75 Interaction via Molecular Docking. Hu, G., X. Li, X. Sun, W. Lu, G. Liu, J. Huang, X. Shen, and Y. Tang, Journal of Molecular Modeling, 2012. [Epub ahead of Print]; PMID[22733274].

[PubMed]. HIV_0622-070512.

11. Synthesis, Crystal Structure and anti-HIV Activity of 2-Adamantyl/Adamantylmethyl-5-aryl-1,3,4-oxadiazoles. Khan, M.U., T. Akhtar, N.A. Al-Masoudi, H. Stoeckli-Evans, and S. Hameed, Medicinal Chemistry, 2012. [Epub ahead of Print]; PMID[22741800].

[PubMed]. HIV_0622-070512.

12. Peptides That Inhibit HIV-1 Integrase by Blocking Its Protein-protein Interactions. Maes, M., A. Loyter, and A. Friedler, FEBS Journal, 2012. [Epub ahead of Print]; PMID[22742518].

[PubMed]. HIV_0622-070512.

13. Intravaginal Ring Delivery of Tenofovir Disoproxil Fumarate for Prevention of HIV and Herpes Simplex Virus Infection. Mesquita, P.M., R. Rastogi, T.J. Segarra, R.S. Teller, N.M. Torres, A.M. Huber, P.F. Kiser, and B.C. Herold, Journal of Antimicrobial Chemotherapy, 2012. 67(7): p. 1730-1738; PMID[22467632].

[PubMed]. HIV_0622-070512.

14. Synthesis and Molecular Modelling Studies of Novel Carbapeptide Analogs for Inhibition of HIV-1 Protease. Pawar, S.A., A.M. Jabgunde, P. Govender, G.E. Maguire, H.G. Kruger, R. Parboosing, M.E. Soliman, Y. Sayed, D.D. Dhavale, and T. Govender, European Journal of Medicinal Chemistry, 2012. 53C: p. 13-21; PMID[22542107].

[PubMed]. HIV_0622-070512.

15. Synthesis and Antiviral Evaluation of C5-Substituted-(1,3-diyne)-2'-deoxyuridines. Sari, O., V. Roy, J. Balzarini, R. Snoeck, G. Andrei, and L.A. Agrofoglio, European Journal of Medicinal Chemistry, 2012. 53C: p. 220-228; PMID[22578783].

[PubMed]. HIV_0622-070512.

16. Inhibition of HIV-1 Integrase Gene Expression by 10-23 DNAzyme. Singh, N., A. Ranjan, S. Sur, R. Chandra, and V. Tandon, Journal of Biosciences, 2012. 37(3): p. 493-502; PMID[22750986].

[PubMed]. HIV_0622-070512.

17. Rapid Assessment of Antiviral Activity and Cytotoxicity of Silver Nanoparticles Using a Novel Application of the Tetrazolium-based Colorimetric Assay. Trefry, J.C. and D.P. Wooley, Journal of Virological Methods, 2012. 183(1): p. 19-24; PMID[22465243].

[PubMed]. HIV_0622-070512.

18. Anti HIV-1 Agents 6. Synthesis and anti-HIV-1 Activity of Indolyl glyoxamides. Wang, Y., N. Huang, X. Yu, L.M. Yang, X.Y. Zhi, Y.T. Zheng, and H. Xu, Medicinal Chemistry, 2012; PMID[22741604].

[PubMed]. HIV_0622-070512.

19. Design, Synthesis and Antiviral Activity of Novel Quinazolinones. Wang, Z., M. Wang, X. Yao, Y. Li, J. Tan, L. Wang, W. Qiao, Y. Geng, Y. Liu, and Q. Wang, European Journal of Medicinal Chemistry, 2012. 53C: p. 275-282; PMID[22546200].

[PubMed]. HIV_0622-070512.

20. A Multi-functional Peptide as an HIV-1 Entry Inhibitor Based on Self-voncentration, Recognition, and Covalent Attachment. Zhao, L., P. Tong, Y.X. Chen, Z.W. Hu, K. Wang, Y.N. Zhang, D.S. Zhao, L.F. Cai, K.L. Liu, Y.F. Zhao, and Y.M. Li, Organic and Biomolecular Chemistry, 2012. [Epub ahead of Print]; PMID[22760295].

[PubMed]. HIV_0622-070512.

ISI Web of Knowledge Citations

21. Synthesis, Anticancer, anti-HIV-1, and Antimicrobial Activity of Some Tricyclic Triazino and Triazolo 4,3-E Purine Derivatives. Ashour, F.A., S.M. Rida, S.A.M. El-Hawash, M.M. ElSemary, and M.H. Badr, Medicinal Chemistry Research, 2012. 21(7): p. 1107-1119; ISI[000304463600019].

[WOS]. HIV_0622-070512.

22. Synthesis and anti-HIV-1 Activity of New Conjugates of 18 Beta- and 18 Alpha-Glycyrrhizic acids with Aspartic acid Esters.. Baltina, L.A., E.S. Chistoedova, R.M. Kondratenko, and O.A. Plyasunova, Chemistry of Natural Compounds, 2012. 48(2): p. 262-266; ISI[000304651800020].

[WOS]. HIV_0622-070512.

23. Design, Synthesis, anti-HIV Evaluation and Molecular Modeling of Piperidine-linked Amino-triazine Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors. Chen, X.W., P. Zhan, X. Liu, Z.H. Cheng, C.C. Meng, S.Y. Shao, C. Pannecouque, E. De Clercq, and X.Y. Liu, Bioorganic & Medicinal Chemistry, 2012. 20(12): p. 3856-3864; ISI[000304486500020].

[WOS]. HIV_0622-070512.

24. QSAR Modeling of Bifunctional Quinolonyl diketo acid Derivatives as Integrase Inhibitors. Dubey, S., N. Abbas, G. Goutham, and P.A. Bhosle, Medicinal Chemistry Research, 2012. 21(7): p. 964-973; ISI[000304463600002].

[WOS]. HIV_0622-070512.

25. Inhibition of HIV-1 Replication with Stable RNAi-mediated Knockdown of Autophagy Factors. Eekels, J.J.M., S. Sagnier, D. Geerts, R.E. Jeeninga, M. Biard-Piechaczyk, and B. Berkhout, Virology Journal, 2012. 9; ISI[000304657800001].

[WOS]. HIV_0622-070512.

26. A Potential in Vitro and in Vivo anti-HIV Drug Screening System for Chinese Herbal Medicines. Feng, L., L. Wang, Y.Y. Ma, M. Li, and G.Q. Zhao, Phytotherapy Research, 2012. 26(6): p. 899-907; ISI[000304816700016].

[WOS]. HIV_0622-070512.

27. A Multivalent HIV-1 Fusion Inhibitor Based on Small Helical Foldamers. Guarise, C., S. Shinde, K. Kibler, G. Ghirlanda, L.J. Prins, and P. Scrimin, Tetrahedron, 2012. 68(23): p. 4346-4352; ISI[000304570000003].

[WOS]. HIV_0622-070512.

28. Pentacycloundecane-diol-based HIV-1 Protease Inhibitors: Biological Screening, 2d NMR, and Molecular Simulation Studies. Honarparvar, B., M.M. Makatini, S.A. Pawar, K. Petzold, M.E.S. Soliman, P.I. Arvidsson, Y. Sayed, T. Govender, G.E.M. Maguire, and H.G. Kruger, ChemMedChem, 2012. 7(6): p. 1009-1019; ISI[000304438900007].

[WOS]. HIV_0622-070512.

29. Phenolic Compounds from Clinopodium urticifolium. Hu, Q.F., H.X. Mu, H.T. Huang, H.Y. Lv, S.L. Li, and G.Y. Yang, Chemistry of Natural Compounds, 2012. 48(2): p. 198-201; ISI[000304651800006].

[WOS]. HIV_0622-070512.

30. A Novel Aspartic Protease with HIV-1 Reverse Transcriptase Inhibitory Activity from Fresh Fruiting Bodies of the Wild Mushroom Xylaria hypoxylon. Hu, Q.X., G.Q. Zhang, R.Y. Zhang, D.D. Hu, H.X. Wang, and T.B. Ng, Journal of Biomedicine and Biotechnology, 2012; ISI[000304939700001].

[WOS]. HIV_0622-070512.

31. Pre-steady State Kinetic Analysis of Cyclobutyl Derivatives of 2 '-Deoxyadenosine 5 '-triphosphate as Inhibitors of HIV-1 Reverse Transcriptase. Kim, J., L.G. Wang, Y.F. Li, K.D. Becnel, K.M. Frey, S.J. Garforth, V.R. Prasad, R.F. Schinazi, D.C. Liotta, and K.S. Anderson, Bioorganic & Medicinal Chemistry Letters, 2012. 22(12): p. 4064-4067; ISI[000304484600042].

[WOS]. HIV_0622-070512.

32. Development of a Unique Small Molecule Modulator of CXCR4. Liang, Z.X., W.Q. Zhan, A.Z. Zhu, Y. Yoon, S.B. Lin, M. Sasaki, J.M.A. Klapproth, H. Yang, H.E. Grossniklaus, J.G. Xu, M. Rojas, R.J. Voll, M.M. Goodman, R.F. Arrendale, J. Liu, C.C. Yun, J.P. Snyder, D.C. Liotta, and H. Shim, PLoS One, 2012. 7(4); ISI[000304780500032].

[WOS]. HIV_0622-070512.

33. Characterization of an HIV-Targeted Transcriptional Gene-silencing RNA in Primary Cells. Turner, A.M.W., A.M. Ackley, M.A. Matrone, and K.V. Morris, Human Gene Therapy, 2012. 23(5): p. 473-483; ISI[000304777700061].

[WOS]. HIV_0622-070512.

34. Structural Modulation Study of Inhibitory Compounds for Ribonuclease H Activity of Human Immunodeficiency Virus Type 1 Reverse Transcriptase. Yanagita, H., S. Fudo, E. Urano, R. Ichikawa, M. Ogata, M. Yokota, T. Murakami, H.G. Wu, J. Chiba, J. Komano, and T. Hoshino, Chemical and Pharmaceutical Bulletin, 2012. 60(6): p. 764-771; ISI[000304727000011].

[WOS]. HIV_0622-070512.

35. Phenolic Compounds from Cestrum aurantiacum. Yin, H.C., Z. Liao, L. Hu, and Q. Hu, Asian Journal of Chemistry, 2012. 24(7): p. 2847-2849; ISI[000305034100004].

[WOS]. HIV_0622-070512.

36. Catechins Containing a Galloyl Moiety as Potential anti-HIV-1 Compounds. Zhao, Y.L., F. Jiang, P. Liu, W. Chen, and K.J. Yi, Drug Discovery Today, 2012. 17(11-12): p. 630-635; ISI[000305094100014].

[WOS]. HIV_0622-070512.

Latent HIV Reactivation Citations

37. Disulfiram Reactivates Latent HIV-1 Expression through Depletion of the Phosphatase and Tensin Homolog (PTEN). Doyon, G., J. Zerbato, J.W. Mellors, and N. Sluis-Cremer, AIDS, 2012; PMID[22739395].

[PubMed]. HIV_0622-070512.

38. Latently Infected Cell Activation: A Way to Reduce the Size of the HIV Reservoir? Forde, J., J.M. Volpe, and S.M. Ciupe, Bulletin of Mathematical Biology, 2012. 74(7): p. 1651-1672; ISI[000304654200009].

[WOS]. HIV_0622-070512.

Patent Citations

39. Preparation of 5,6,7,8-Tetrahydro[1]benzothieno[2,3-B]pyridin-3-ylacetic acid Derivatives for Treatment of HIV Infection. Bell, A.S., I.B. Gardner, D.C. Pryde, F.M. Wakenhut, and K.R. Gibson. Patent. 2012. 2011-IB54852 2012066442: 64pp.

[Patent]. HIV_0622-070512.

40. Preparation of Phenylpyrimidoindazolylpentanoic acid Derivatives and Analogs for Use as Antiviral Agents. Chaltin, P., F. Christ, Z. Debyser, M. De Maeyer, A. Marchand, D. Marchand, and A. Voet. Patent. 2012. 2011-EP70089 2012065963: 110pp.

[Patent]. HIV_0622-070512.

41. Preparation of Novel Amides of Amino Acids and Analogs as Antiviral Agents. Chen, P., D. Zhou, D. Pryde, A. Bell, T. Li, Z. He, and Z.-W. Cai. Patent. 2012. 2011-US60370 2012065062: 182pp.

[Patent]. HIV_0622-070512.

42. A Process for the Preparation of Hexahydrofurofuran Derivatives for Use as anti-HIV Agents. Ghosh, A.K. and C.D. Martyr. Patent. 2012. 2011-US62611 2012075122: 41pp.

[Patent]. HIV_0622-070512.

43. Peptide Ligands for the Nucleocapsid Protein Ncp7 for Use as AIDS Drugs. Mely, Y., J. Langedijk, V. Shvadchak, and J.-L. Darlix. Patent. 2012. 2011-FR52909 2012076822: 70pp.

[Patent]. HIV_0622-070512.

44. Preparation of Pyrimidoazepines as HIV Integrase Inhibitors Useful in the Treatment of Hiv Infection and AIDS. Peese, K., B.N. Naidu, M. Patel, C. Li, and M.A. Walker. Patent. 2012. 2011-US63910 2012078844: 67pp.

[Patent]. HIV_0622-070512.

45. Monophosphate Prodrugs of DAPD and Analogs for Viral Infection and Cancer Therapy. Schinazi, R.F. and S.J. Coats. Patent. 2012. 2011-306967

20120142627: 48pp.

[Patent]. HIV_0622-070512.

46. Preparation of Piperazine Alkyl Amides as HIV Attachment Inhibitors. Wang, T., Z. Zhang, Z. Yin, J.F. Kadow, and N.A. Meanwell. Patent. 2012. 2011-US62804 2012075235: 107pp.

[Patent]. HIV_0622-070512.

47. Preparation of Tetrahydroisoquinoline Derivatives as CXCR4 Receptor Modulators. Wilson, L., D.C. Liotta, J. Wiseman, and M.G. Natchus. Patent. 2012. 2011-US63007 2012075362: 62pp.

[Patent]. HIV_0622-070512.